QUOTED. 26 May 2021. Robert Ford.
The global market for blood glucose monitoring devices is expected to rise from $9.1bn in 2019 to $19.7bn by 2025, a CAGR of 13.8%. See what Abbott’s CEO Robert Ford said about his outlook for the company’s flagship FreeStyle Libre CGM.
“We grew double-digits … Libre is growing rapidly.” – Robert Ford, CEO, Abbott
- Find out more: Market Intel: Glucose Monitor Market Set To Explode As Patients Access Better Devices
Click here for a free trial of Medtech Insight